198 related articles for article (PubMed ID: 15525445)
1. A pharmacokinetic and pharmacodynamic study of desmopressin: evaluating sex differences and the effect of pre-treatment with piroxicam, and further validation of an indirect response model.
Odeberg JM; Callréus T; Lundin S; Roth EB; Höglund P
J Pharm Pharmacol; 2004 Nov; 56(11):1389-98. PubMed ID: 15525445
[TBL] [Abstract][Full Text] [Related]
2. The influence of lithium on the antidiuretic effect of desmopressin.
Callréus T; Holmquist IB; Lundin S; Höglund P
J Pharm Pharmacol; 2002 Sep; 54(9):1279-85. PubMed ID: 12356283
[TBL] [Abstract][Full Text] [Related]
3. A pharmacokinetic and pharmacodynamic comparison of desmopressin administered as whole, chewed and crushed tablets, and as an oral solution.
Argenti D; Ireland D; Heald DL
J Urol; 2001 May; 165(5):1446-51. PubMed ID: 11342894
[TBL] [Abstract][Full Text] [Related]
4. Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects.
Rittig S; Jensen AR; Jensen KT; Pedersen EB
Clin Endocrinol (Oxf); 1998 Feb; 48(2):235-41. PubMed ID: 9579238
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years.
Rembratt A; Graugaard-Jensen C; Senderovitz T; Norgaard JP; Djurhuus JC
Eur J Clin Pharmacol; 2004 Aug; 60(6):397-402. PubMed ID: 15197520
[TBL] [Abstract][Full Text] [Related]
6. The duration of antidiuretic response of two desmopressin nasal sprays.
Eller N; Kollenz CJ; Bauer P; Hitzenberger G
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):494-500. PubMed ID: 9760011
[TBL] [Abstract][Full Text] [Related]
7. Temporal delays and individual variation in antidiuretic response to desmopressin.
Juul KV; Erichsen L; Robertson GL
Am J Physiol Renal Physiol; 2013 Feb; 304(3):F268-78. PubMed ID: 23136002
[TBL] [Abstract][Full Text] [Related]
8. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
De Guchtenaere A; Raes A; Vande Walle C; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J
J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect.
Hvistendahl GM; Riis A; Nørgaard JP; Djurhuus JC
BJU Int; 2005 Apr; 95(6):804-9. PubMed ID: 15794787
[TBL] [Abstract][Full Text] [Related]
10. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.
Yamaguchi O; Nishizawa O; Juul KV; Nørgaard JP
BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147
[TBL] [Abstract][Full Text] [Related]
11. Gender difference in antidiuretic response to desmopressin.
Juul KV; Klein BM; Sandström R; Erichsen L; Nørgaard JP
Am J Physiol Renal Physiol; 2011 May; 300(5):F1116-22. PubMed ID: 21367921
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of pharmacodynamics and bioavailability of 2 different desmopressin nasal sprays.
Eller N; Kollenz CJ; Hitzenberger G
Int J Clin Pharmacol Ther; 1998 Mar; 36(3):139-45. PubMed ID: 9562229
[TBL] [Abstract][Full Text] [Related]
13. Plasma pharmacokinetics of desmopressin following sublingual administration: an exploratory dose-escalation study in healthy male volunteers.
Steiner IM; Kaehler ST; Sauermann R; Rinösl H; Müller M; Joukhadar C
Int J Clin Pharmacol Ther; 2006 Apr; 44(4):172-9. PubMed ID: 16625986
[TBL] [Abstract][Full Text] [Related]
14. Indirect-response modeling of desmopressin at different levels of hydration.
Callréus T; Odeberg J; Lundin S; Höglund P
J Pharmacokinet Biopharm; 1999 Oct; 27(5):513-29. PubMed ID: 10948696
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus].
Merola B; Caruso E; De Chiara G; Rossi E; Longobardi S; Colao A; Brusco G; Lombardi G; Biraghi M
Minerva Med; 1992 Dec; 83(12):805-13. PubMed ID: 1491760
[TBL] [Abstract][Full Text] [Related]
16. Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam.
Perini JA; Vianna-Jorge R; Brogliato AR; Suarez-Kurtz G
Clin Pharmacol Ther; 2005 Oct; 78(4):362-9. PubMed ID: 16198655
[TBL] [Abstract][Full Text] [Related]
17. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease.
Sharthkumar A; Greist A; Di Paola J; Winay J; Roberson C; Heiman M; Herbert S; Parameswaran R; Shapiro A
Haemophilia; 2008 May; 14(3):539-48. PubMed ID: 18312368
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and pharmacokinetics of desmopressin in elderly men.
Hougaard C; Matthiesen TB; Rittig S; Djurhuus JC
Scand J Urol Nephrol Suppl; 1997; 183():53-4. PubMed ID: 9165608
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in nighttime plasma arginine vasopressin and delayed compensatory urine output in the elderly population after desmopressin.
Hvistendahl GM; Frøkiaer J; Nielsen S; Djurhuus JC
J Urol; 2007 Dec; 178(6):2671-6. PubMed ID: 17945283
[TBL] [Abstract][Full Text] [Related]
20. Effect of iontophoretic patterns on in vivo antidiuretic response to desmopressin acetate administered transdermally.
Nakakura M; Terajima M; Kato Y; Hayakawa E; Ito K; Kuroda T
J Drug Target; 1995; 2(6):487-92. PubMed ID: 7773610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
